This report was recently updated on April 12 2024 with the latest and most recent
market numbers
Global Womens Health Diagnostics Market Size, Trends, and Analysis - Forecasts To 2026 By Application (Cancer (Breast Cancer Testing, Ovarian Cancer Testing, Cervical Cancer Testing), Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Prenatal Testing), By End-User (Hospital and Diagnostics Centers, Home), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Women’s health diagnostics refer to the diagnostics techniques used to understand the ailments affecting women while some diseases like cancer and infectious diseases affect all genders, some like breast and ovarian cancer are women-centric. The women’s health diagnostic market has been driven by the growing number of diseases affecting women and the awareness of such diseases. There have been increasing incidences of various infectious diseases like urinary tract infections and hepatitis among women. Early diagnosis of diseases like cancer will increase the chance of survival and better management of disease progression. To this effect, various diagnostic techniques are available in the market like breast MRI, mammography, bone density testing, and ultrasounds.
The growing incidence of urinary tract infections among women has also contributed to the growth of the women’s health diagnostic market. Women under the age of 50, are 30 times more prone to develop a urinary tract infection. The growing participation of women in the workplace has also improved the demand and awareness of diagnostic testing among women. Women are becoming increasingly aware of diseases and are slowly having the means to do so without being dependent on their male counterparts. Health insurance coverage of various diagnostic techniques and improved accessibility of insurance schemes to women has also increased the demand for women’s health diagnostics.
Women during and before pregnancies, undergo various testing procedures to ensure their health and their child’s health. Growing instances of chromosomal imbalances in the fetus have been increasing the demand for prenatal diagnostics and fertility treatments and diagnostics are also becoming increasingly common.
Developing nations and underdeveloped nations are beginning to release various schemes and initiatives under their governments to improve the health of their women. Large sections of women in such nations are malnourished and suffer from a lack of accessibility to various health facilities. Government initiatives are being developed to help women get the care they deserve. These initiatives and schemes are also expected to lead to the growth of the women’s health diagnostic market.
Based on the ailments, the women’s health diagnostics market can be segmented into cancer, infectious disease testing, osteoporosis testing, pregnancy and fertility testing, and prenatal testing. The cancer segment is expected to hold the largest share of the revenues during the forecast period. The cancer segment is comprised of various forms of cancer testing like breast cancer testing, cervical cancer testing, and ovarian cancer testing. Cancer has become one of the most common and deadly diseases affecting large segments of the population. Early diagnosis of cancer has been shown to improve the chances of survival and management of the disease.
The growing awareness of cancer diagnostics has been the major driver of the segment. The cancer testing segment has also been positively impacted by the growth of diagnostic technologies. Technological advancements have made it possible to diagnose cancer with greater efficiency and improved imaging of cancer. The development of home testing kits and methods and other forms of diagnosis has led to the dominance of this segment.
Based on the end-user of diagnostics, the women’s health diagnostics market has been segmented into hospitals and diagnostic centers, and home segments. The hospitals and diagnostic centers held the largest share of the market. Customers prefer getting tested at reputed hospitals and diagnostic centers as they can get professional opinions that can be invaluable to them. As most diagnostics are carried out as part of a diagnosis ordered by the physician, the hospitals and diagnostic centers have held the largest share of the revenues. Hospitals and diagnostic centers have large funding that allows them to have expensive equipment that can be used for better diagnosis. The home segment is expected to register the fastest growth rate. Growing awareness of various diseases has increased the demand for home and point-of-care testing. Vendors are also increasing the production of various testing kits that can be used by individuals at home. The growing desire for people to get tested regularly and for it to be carried out cheaply are expected to result in the growth of the home segment during the forecast period.
The North American region held the dominant share of the market. North American countries spend heavily on healthcare which has improved the facilities available. Diagnostic equipment is improving year on year as technological advancements make them more efficient and lead to better diagnosis. The region has various vendors that implement the latest technologies and large funding for testing has led to the dominance of the North American region. Government initiatives to improve awareness of various diseases and the need for early diagnosis have also played a part in the dominance of the North American region in the women’s health diagnostics market.
Moreover, the APAC region is expected to register the fastest growth rate during the forecast period. The improvements in testing facilities and the growing awareness of women’s health are expected to increase the demand for women’s health testing in the APAC region. Increased participation of women in the workplace is expected to increase the demand for women’s health diagnostics in the APAC region. The growing number of woman-centric initiatives to improve women’s health in countries like India are also expected to increase the demand for women’s health diagnostics in the region.
Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., Koninklijke Philips N.V., bioMérieux SA, Hologic, Inc., Abbott, GE Healthcare, PerkinElmer, Inc., and Siemens Healthcare Private Limited, among others, are the major vendors competing in the women’s health diagnostics market.
Please note: This is not an exhaustive list of companies profiled in the report.
In September 2019, Roche Diagnostics Ltd. obtained FDA approval for the cobas HBV and cobas HCV viral load test assays, which can be used in its cobas 6800 and cobas 8800 Systems.
Chapter 1 Methodology
1.1 Market scope & definitions
1.2 Estimates & forecast calculation
1.3 Historical data overview and validation
1.4 Data sources
1.4.1 Secondary
1.4.2 Primary
Chapter 2 Report Outlook
2.1 Global Women’s Health Diagnostics Industry Overview, 2016-2026
2.1.1 Industry overview
2.1.2 Product overview
2.1.3 Type overview
2.1.4 Regional overview
Chapter 3 Women’s Health Diagnostics Market Trends
3.1 Market segmentation
3.2 Industry background, 2019-2026
3.3 Market key trends
3.3.1.1 The growing awareness of women’s health diagnostics techniques.
3.3.2 Industry challenges
3.3.2.1 Increasing adoption of refurbished diagnostic imaging systems
3.4 Prospective growth scenario
3.4.1 Product growth scenario
3.4.2 Type growth scenario
3.5 COVID-19 influence over industry growth
3.6 Porter’s analysis
3.7 PESTEL analysis
3.8 Value chain & supply chain analysis
3.9 Regulatory framework
3.9.1 North America
3.9.2 Europe
3.9.3 APAC
3.9.4 LATAM
3.9.5 MEA
3.10 Technology overview
3.11 Market share analysis, 2020
3.11.1 Company positioning overview, 2020
Chapter 4 Global Women’s Health Diagnostics Market, By End-User
4.1 Product Outlook
4.2 Hospital and Home Diagnostics Centers
4.2.1 Market size, By Region, 2016-2026 (USD Billion)
4.3 Home
4.3.1 Market size, By Region, 2016-2026 (USD Billion)
Chapter 5 Global Women’s Health Diagnostics Market, By Application
5.1 Type Outlook
5.2 Cancer
5.2.1 Market size, By Region, 2016-2026 (USD Billion)
5.3 Infectious Disease Testing
5.3.1 Market size, By Region, 2016-2026 (USD Billion)
5.4 Osteoporosis Testing
5.4.1 Market size, By Region, 2016-2026 (USD Billion)
5.5 Pregnancy and Fertility Testing
5.5.1 Market size, By Region, 2016-2026 (USD Billion)
5.6 Prenatal Testing
5.6.1 Market size, By Region, 2016-2026 (USD Billion)
Chapter 6 Global Women’s Health Diagnostics Market, By Region
6.1 Regional outlook
6.2 North America
6.2.1 Market size, By Country 2016-2026 (USD Billion)
6.2.2 Market size, By End-User, 2016-2026 (USD Billion)
6.2.3 Market size, By Application, 2016-2026 (USD Billion)
6.2.4 U.S.
6.2.4.1 Market size, By End-User, 2016-2026 (USD Billion)
6.2.4.2 Market size, By Application, 2016-2026 (USD Billion)
6.2.5 Canada
6.2.5.1 Market size, By End-User, 2016-2026 (USD Billion)
6.2.5.2 Market size, By Application, 2016-2026 (USD Billion)
6.3 Europe
6.3.1 Market size, By Country 2016-2026 (USD Billion)
6.3.2 Market size, By End-User, 2016-2026 (USD Billion)
6.3.3 Market size, By Application, 2016-2026 (USD Billion)
6.3.4 Germany
6.2.4.1 Market size, By End-User, 2016-2026 (USD Billion)
6.2.4.2 Market size, By Application, 2016-2026 (USD Billion)
6.3.5 UK
6.3.5.1 Market size, By End-User, 2016-2026 (USD Billion)
6.3.5.2 Market size, By Application, 2016-2026 (USD Billion)
6.3.6 France
6.3.6.1 Market size, By End-User, 2016-2026 (USD Billion)
6.3.6.2 Market size, By Application, 2016-2026 (USD Billion)
6.3.7 Italy
6.3.7.1 Market size, By End-User, 2016-2026 (USD Billion)
6.3.7.2 Market size, By Application, 2016-2026 (USD Billion)
6.3.8 Spain
6.3.8.1 Market size, By End-User, 2016-2026 (USD Billion)
6.3.8.2 Market size, By Application, 2016-2026 (USD Billion)
6.3.9 Russia
6.3.9.1 Market size, By End-User, 2016-2026 (USD Billion)
6.3.9.2 Market size, By Application, 2016-2026 (USD Billion)
6.4 Asia Pacific
6.4.1 Market size, By Country 2016-2026 (USD Billion)
6.4.2 Market size, By End-User, 2016-2026 (USD Billion)
6.4.3 Market size, By Application, 2016-2026 (USD Billion)
6.4.4 China
6.4.4.1 Market size, By End-User, 2016-2026 (USD Billion)
6.4.4.2 Market size, By Application, 2016-2026 (USD Billion)
6.4.5 India
6.4.5.1 Market size, By End-User, 2016-2026 (USD Billion)
6.4.5.2 Market size, By Application, 2016-2026 (USD Billion)
6.4.6 Japan
6.4.6.1 Market size, By End-User, 2016-2026 (USD Billion)
6.4.6.2 Market size, By Application, 2016-2026 (USD Billion)
6.4.7 Australia
6.4.7.1 Market size, By End-User, 2016-2026 (USD Billion)
6.4.7.2 Market size, By Application, 2016-2026 (USD Billion)
6.4.8 South Korea
6.4.8.1 Market size, By End-User, 2016-2026 (USD Billion)
6.4.8.2 Market size, By Application, 2016-2026 (USD Billion)
6.5 Latin America
6.5.1 Market size, By Country 2016-2026 (USD Billion)
6.5.2 Market size, By End-User, 2016-2026 (USD Billion)
6.5.3 Market size, By Application, 2016-2026 (USD Billion)
6.5.4 Brazil
6.5.4.1 Market size, By End-User, 2016-2026 (USD Billion)
6.5.4.2 Market size, By Application, 2016-2026 (USD Billion)
6.5.5 Mexico
6.5.5.1 Market size, By End-User, 2016-2026 (USD Billion)
6.5.5.2 Market size, By Application, 2016-2026 (USD Billion)
6.5.6 Argentina
6.5.6.1 Market size, By End-User, 2016-2026 (USD Billion)
6.5.6.2 Market size, By Application, 2016-2026 (USD Billion)
6.6 MEA
6.6.1 Market size, By Country 2016-2026 (USD Billion)
6.6.2 Market size, By End-User, 2016-2026 (USD Billion)
6.6.3 Market size, By Application, 2016-2026 (USD Billion)
6.6.4 Saudi Arabia
6.6.4.1 Market size, By End-User, 2016-2026 (USD Billion)
6.6.4.2 Market size, By Application, 2016-2026 (USD Billion)
6.6.5 UAE
6.6.5.1 Market size, By End-User, 2016-2026 (USD Billion)
6.6.5.2 Market size, By Application, 2016-2026 (USD Billion)
6.6.6 South Africa
6.6.6.1 Market size, By End-User, 2016-2026 (USD Billion)
6.6.6.2 Market size, By Application, 2016-2026 (USD Billion)
Chapter 7 Company Landscape
7.1 Competitive analysis, 2020
7.2 Becton, Dickinson and Company
7.2.1 Company overview
7.2.2 Financial analysis
7.2.3 Strategic positioning
7.2.4 Info graphic analysis
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company overview
7.3.2 Financial analysis
7.3.3 Strategic positioning
7.3.4 Info graphic analysis
7.4 Koninklijke Philips N.V.
7.4.1 Company overview
7.4.2 Financial analysis
7.4.3 Strategic positioning
7.4.4 Info graphic analysis
7.5 BioMérieux SA
7.5.1 Company overview
7.5.2 Financial analysis
7.5.3 Strategic positioning
7.5.4 Info graphic analysis
7.6 Hologic, Inc.
7.6.1 Company overview
7.6.2 Financial analysis
7.6.3 Strategic positioning
7.6.4 Info graphic analysis
7.7 Abbott Laboratories
7.7.1 Company overview
7.7.2 Financial analysis
7.7.3 Strategic positioning
7.7.4 Info graphic analysis
7.8 GE Healthcare
7.8.1 Company overview
7.8.2 Financial analysis
7.8.3 Strategic positioning
7.8.4 Info graphic analysis
7.9 Siemens Healthcare Private Limited
7.9.1 Company overview
7.9.2 Financial analysis
7.9.3 Strategic positioning
7.9.4 Info graphic analysis
7.10 PerkinElmer, Inc.
7.10.1 Company overview
7.10.2 Financial analysis
7.10.3 Strategic positioning
7.10.4 Info graphic analysis
7.11 Quest Diagnostics, Inc.
7.11.1 Company overview
7.11.2 Financial analysis
7.11.3 Strategic positioning
7.11.4 Info graphic analysis
7.12 Other Companies
7.12.1 Company overview
7.12.2 Financial analysis
7.12.3 Strategic positioning
7.12.4 Info graphic analysis
The Global Womens Health Diagnostics Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Womens Health Diagnostics Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
